Novartis (NOVN)
Basel-based pharmaceutical company created by the 1996 merger of Ciba-Geigy and Sandoz, now a pure-play innovative-medicines business after spinning off Alcon and Sandoz. Key franchises include cardiovascular, oncology and immunology drugs.
- Legal name
- Novartis AG
- Ticker
- NOVN
- Exchange
- SIX Swiss Exchange · MIC XSWX
- Country
- Switzerland
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Market cap ≈
- $230bn (approx., seed-0.6 · 2026-08-29)
- Reporting currency
- CHF
- Founded
- 1996
- Website
- www.novartis.com
- LEI
- 5493007HIVTX6SY6XD66 (GLEIF)
- ISIN
- CH0012005267 (check digit validated)
- FIGI
- BBG001SD31N7 (share class, OpenFIGI)
Graph connections view in graph →
lists_onSIX Swiss Exchange
domiciled_inSwitzerland
Sector peers — Healthcare
Eli Lilly · UnitedHealth Group · Johnson & Johnson · AbbVie · Merck & Co. · Thermo Fisher Scientific
Compare: NOVN vs LLY · NOVN vs UNH · NOVN vs JNJ
Identifier crosswalk
| Standard | Value | What it answers |
|---|---|---|
| Ticker | NOVN | Venue-local shorthand — ambiguous across markets |
| MIC | XSWX | ISO 10383 — the venue |
| ISIN | CH0012005267 | ISO 6166 — the security |
| LEI | 5493007HIVTX6SY6XD66 | ISO 17442 — the legal entity |
| FIGI | BBG001SD31N7 | OpenFIGI — instrument, share class |
One entity, six naming systems. Each linked code opens its reverse-lookup page; the validator checks any code's check digit. CUSIP is shown because it is embedded in US/CA ISINs — we verify it, we do not redistribute CUSIP data.
Approximate reference values from public sources · seed-0.6 · 2026-08-29 · not real-time. See data & methodology.